Projects (504)

Sort by: Name | Date

10 | 25 | 50 | 100

2/11

3 A B C D E F H I J K L M N O P R S T U V W Z All

The role of bacterial toxins in diabetes (01/07/2007 - 30/06/2010)

Wann, Kenneth

The involvement of lipid raft proteins in the processing of amyloid precursor protein (01/03/2012 - 30/06/2015)

Kidd, Emma

The influence of altered endocytic protein expression on the predisposition to develop Alzheimer's disease (08/09/2014 - 30/06/2016)

Kidd, Emma

The identification of B anthracis specific DNA probes (01/02/2015 - 31/10/2015)

Baillie, Les

The GDNF neurosurgical clinical trial: listening to and learning from the participant experience (19/10/2020 - 18/01/2022)

Lane, Emma

The first preclinical analysis for a novel magnetically directed cancer treatment (01/08/2016 - 30/04/2017)

Brancale, Andrea

The discovery of mitochondrial-targeting nucleotide prodrugs for the treatment of mitochondrial diseases (01/01/2019 - 30/04/2019)

Mehellou, Youcef

The design synthesis and evaluation of novel agents acting in the CNS (27/10/2014 - 08/01/2016)

Mcguigan, Christopher

The controlled and targeted release of Potassium permanganates from a matrix into an aqueous interface (01/12/2014 - 30/09/2015)

The controlled and targeted delivery of potassium permanganate micro particles to wounds utilising the permipatch technology (01/10/2016 - 30/09/2017)

The contribution of the exosporium of bacillus anthracis to survival (ROLEEXOSPORIUM) (01/11/2007 - 31/12/2010)

Baillie, Les

The biological evaluation of protide (01/03/2013 - 30/06/2014)

Mcguigan, Christopher

Testng of the activity of Sanytol disinfectant wipes against Pseudononas aeruginosa (01/09/2014 - 30/09/2014)

Maillard, Jean-Yves

Testing the virucidal activity of formulations against poliovirus (01/07/2015 - 31/12/2015)

Maillard, Jean-Yves

Testing the virucidal activity of formulations against poliovirus (01/02/2016 - 29/02/2016)

Maillard, Jean-Yves

Testing the Efficacy of two wipes based on the ASTM 2967-15 (01/07/2016 - 31/07/2016)

Maillard, Jean-Yves

Testing the efficacy of pre-wetted sporicidal wipes (01/09/2016 - 31/10/2016)

Maillard, Jean-Yves

Testing the antimicrobial activity of product (25/09/2017 - 31/12/2017)

Maillard, Jean-Yves

Testing of the sporicidal activity of wipes against Clostridium difficile (29/04/2013 - 02/06/2013)

Maillard, Jean-Yves

Testing of the sporicidal activity of "Schulke" wipe against clostridium difficile (01/09/2012 - 14/09/2012)

Maillard, Jean-Yves

Testing of the sporicidal activity of PDI wipe against clostridium difficile (01/08/2011 - 14/08/2011)

Maillard, Jean-Yves

Testing of the sporicidal activity of 3 new products against clostridium difficle (16/01/2012 - 31/01/2012)

Maillard, Jean-Yves

Testing of the sporicidal activity of 10 commercially available wipes against clostridium difficile (01/03/2009 - 13/01/2010)

Maillard, Jean-Yves

Testing of the sporicidal activity of 10 commercially available wipes against clostridium difficile (29/03/2010 - 30/09/2011)

Maillard, Jean-Yves

Testing of the sporiciadal activity of wipes against clostridium difficile (10/04/2012 - 13/04/2012)

Maillard, Jean-Yves

Testing of the propensity of OxyBAC F31 RO (1331) to induce/select/trigger/bacterial resistance (01/07/2014 - 21/07/2014)

Maillard, Jean-Yves

Testing of the propensity of Oxy BAC F31 RO (1331) to induce/select/trigger bacterial resistance (01/12/2014 - 09/02/2015)

Maillard, Jean-Yves

Testing of the new sporicidal activity of 3 new products against clostridium difficile (30/01/2012 - 29/04/2012)

Maillard, Jean-Yves

Testing of the efficacy of Byotrol wipes against two bacterial contaminants (14/05/2012 - 31/05/2012)

Maillard, Jean-Yves

Testing of the activity of antimicrobial wipe against clostridium difficile and MRSA (01/09/2012 - 14/09/2012)

Maillard, Jean-Yves

Testing of the activity of antimicrobial wipe against clostridium difficile and MRSA (28/01/2013 - 27/02/2013)

Maillard, Jean-Yves

Testing of contamination of Alcoblow(r) (01/04/2013 - 14/04/2013)

Maillard, Jean-Yves

Testing for broad spectrum efficacy of photosensitiser-based formulation (01/01/2020 - 31/12/2020)

Maillard, Jean-Yves

Testing antimicrobial material acitvity (14/09/2015 - 13/01/2016)

Maillard, Jean-Yves

Testing a novel chemotherapy delivery system using two dinitrobenzamide mustard prodrugs (01/10/2015 - 30/09/2018)

Mcguigan, Christopher

Telehealth enabled medicines for care home residents (01/09/2014 - 31/12/2021)

James, Delyth

Technology Transfer Workshop (15/03/2017 - 31/12/2017)

Gumbleton, Mark

Targetting zinc signalling to prevent cell division in cancer (01/10/2015 - 30/09/2018)

Taylor, Kathryn

Targeting zinc signalling to prevent cell division in cancer (01/10/2016 - 30/09/2018)

Taylor, Kathryn

Targeting of interleukin-13 receptor (IL-13R) a2 expressing pancreatic cancer by a novel hybrid lytic peptide drug (01/10/2016 - 15/11/2018)

Brancale, Andrea

Targeting natural products to counter the challenge of MRSA (01/10/2014 - 30/09/2017)

Mcguigan, Christopher

Targeting CtIP to sensitise cancer cells to DNA-damaging agents (01/11/2016 - 31/03/2018)

Brancale, Andrea

Targeted metabolic inhibition of T-lymphocytes: Directing immunity during human disease (01/10/2016 - 15/11/2018)

Brancale, Andrea

Synthetic routes to the tumour proliferation biomarker FLT and ProTide analogues for position emission tomography (PET) imaging (01/01/2010 - 01/01/2013)

Westwell, Andrew

Synthetic routes of 18F labelled gemicitabine and related 2"-fluoronucleotides (01/10/2011 - 30/09/2014)

Westwell, Andrew

Synthesis of novel indole derivatives as apoptosis-inducing antitumour agents (01/01/2007 - 01/01/2010)

Westwell, Andrew

Surfoxidants for universal decontamination (01/07/2019 - 31/10/2019)

Maillard, Jean-Yves

Suldecki - ASM Micro 2019 Conference (01/06/2019 - 02/06/2019)

Maillard, Jean-Yves

Sugar phosphates for osteoarthritis (01/11/2005 - 16/11/2009)

Mcguigan, Christopher

Substrate disinfectant active binding study (01/12/2016 - 30/09/2017)

Maillard, Jean-Yves

10 | 25 | 50 | 100

2/11

Projects (504)

Our policy towards the use of cookies